> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER AI Pharmacovigilance Meeting Program
- URL: https://www.fdaweb.com/cder-ai-pharmacovigilance-meeting-program/
- Published: 2024-06-11T12:00:00.000Z
- Updated: 2026-09-14T14:33:00.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157150

*Federal Register* notice: CDER is announcing the Emerging Drug Safety Technology Meeting program, intended to provide stakeholders involved in pharmacovigilance (PV) activities an opportunity to meet with CDER staff to discuss their research, development, and use of artificial intelligence and other emerging technologies in PV. The Center says the program’s goal in its initial phase is to facilitate mutual learning and discussion of the pharmaceutical industry’s application of these technologies to PV, including efforts to validate and verify relevant models. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-06-11/pdf/2024-12770.pdf?ref=fdaweb.com).